Publications in peer-reviewed journals

  1. Baraka V1, Delgado-Ratto, C1, et al. (2017). Different origin and dispersal of sulfadoxine-resistant Plasmodium falciparum haplotypes between Eastern Africa and Democratic Republic of Congo. International Journal of Antimicrobial Agents, http://dx.doi.org/doi: 10.1016/j.ijantimicag.2016.12.007 (1equal contribution).
  2. Delgado-Ratto, C., et al. (2016). "Population Genetics of Plasmodium vivax in the Peruvian Amazon." PLoS Negl Trop Dis 10(1): e0004376.
  3. Muhindo Mavoko, H., et al. (2016). "Uncomplicated Clinical Malaria Features, the Efficacy of Artesunate-Amodiaquine and Their Relation with Multiplicity of Infection in the Democratic Republic of Congo." PLoS One 11(6): e0157074.
  4. Hong, N. V., et al. (2016). "Population Genetics of Plasmodium vivax in Four Rural Communities in Central Vietnam." PLoS Negl Trop Dis 10(2): e0004434.
  5. Baraka, V., et al. (2015). "In Vivo Selection of Plasmodium falciparum Pfcrt and Pfmdr1 Variants by Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Burkina Faso." Antimicrob Agents Chemother 59(1): 734-737.
  6. Delgado-Ratto, C., et al. (2014). "Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon." Malar J 13: 8.
  7. Van den Eede, P., et al. (2011). "Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study." PLoS One 6(1): e16257.
  8. Van den Eede, P., et al. (2010). "Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon." Malar J 9: 151.
  9. Grande, T., et al. (2007). "A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru." PLoS One 2(10): e1101.